Titan Medical Inc. Registration statement for securities of certain foreign private issuers

Registration statement for securities of certain foreign private issuers

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Segmented Reporting

Segmented Reporting

12 Months Ended

Dec. 31, 2019

12.	SEGMENTED REPORTING

The Company operates in a single reportable operating segment – the research and development of the Company’s single-port robotic surgical system, the next generation of surgical robotic platform. The Company’s long-term assets are domiciled in Toronto, Canada.